JEFFREY J. KIMBELL & ASSOCIATES, INC.
JEFFREY J. KIMBELL & ASSOCIATES, INC. is named as the registrant in 64 lobbying reports we hold for 2026-Q2, for 64 clients. 0 reports of 64 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client, sort A to Z | Amount the report states, by quarter, sort largest first | Reports, sort smallest first |
|---|---|---|
| ACCURAY INCORPORATED | 2026-Q2: $40,000 in income | 1 |
| ACME UNITED CORPORATION | 2026-Q2: $10,000 in income | 1 |
| AGIOS PHARMACEUTICALS, INC. | 2026-Q2: $10,000 in income | 1 |
| ALEXION PHARMACEUTICALS | 2026-Q2: $10,000 in income | 1 |
| AMGEN INC. | 2026-Q2: $7,500 in income | 1 |
| ARDELYX, INC. | 2026-Q2: $40,000 in income | 1 |
| ASTELLAS PHARMA US | 2026-Q2: $40,000 in income | 1 |
| ATARA BIOTHERAPEUTICS, INC. | 2026-Q2: $10,000 in income | 1 |
| ATEA PHARMACEUTICALS, INC. | 2026-Q2: $10,000 in income | 1 |
| AVALON HEALTHCARE SOLUTIONS | 2026-Q2: $10,000 in income | 1 |
| BIOTISSUE | 2026-Q2: $9,000 in income | 1 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2026-Q2: $40,000 in income | 1 |
| BROOKDALE SENIOR LIVING INC. | 2026-Q2: $40,000 in income | 1 |
| CAPRICOR | 2026-Q2: $10,000 in income | 1 |
| CATALYST PHARMACEUTICALS | 2026-Q2: $30,000 in income | 1 |
| COALITION FOR AFFORDABLE PET CARE | 2026-Q2: $20,000 in income | 1 |
| COLLEGIUM PHARMACEUTICAL | 2026-Q2: $10,000 in income | 1 |
| COLOPLAST CORP | 2026-Q2: $10,000 in income | 1 |
| GALVANIZE THERAPEUTICS, INC. | 2026-Q2: No amount stated | 1 |
| GAURDANT HEALTH | 2026-Q2: $10,000 in income | 1 |
| GENETIX BIOTHERAPEUTICS | 2026-Q2: $15,000 in income | 1 |
| GENUS LIFESCIENCES | 2026-Q2: $36,000 in income | 1 |
| GILEAD SCIENCES, INC. | 2026-Q2: $75,000 in income | 1 |
| GLAUKOS CORPORATION (FKA AVEDRO, INC.) | 2026-Q2: $20,000 in income | 1 |
| HARMONY BIOSCIENCES, LLC | 2026-Q2: $20,000 in income | 1 |
| HARROW INC. | 2026-Q2: $20,000 in income | 1 |
| ILLUMINA, INC. | 2026-Q2: $18,750 in income | 1 |
| INDEMED | 2026-Q2: $10,000 in income | 1 |
| INDIVIOR INC. | 2026-Q2: $10,000 in income | 1 |
| INNOVAGE | 2026-Q2: $20,000 in income | 1 |
| INSMED, INC. | 2026-Q2: $10,000 in income | 1 |
| INSTITUTE FOR GENE THERAPIES | 2026-Q2: $20,000 in income | 1 |
| KENDAL NUTRICARE LTD | 2026-Q2: $20,000 in income | 1 |
| LIVANOVA USA INC | 2026-Q2: $30,000 in income | 1 |
| MAGNOLIA MEDICAL TECHNOLOGIES, INC. | 2026-Q2: $10,000 in income | 1 |
| MAGNUS MEDICAL, INC. | 2026-Q2: $10,000 in income | 1 |
| MANNKIND CORPORATION | 2026-Q2: $10,000 in income | 1 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 2026-Q2: $10,000 in income | 1 |
| MOBIA MEDICAL, INC (FKA MICROTRANSPONDER) | 2026-Q2: $10,000 in income | 1 |
| MOMENTOUS | 2026-Q2: $15,000 in income | 1 |
| NEURALINK CORP. | 2026-Q2: $60,000 in income | 1 |
| NEUROTECH PHARMACEUTICALS | 2026-Q2: $10,000 in income | 1 |
| NEUSPERA MEDICAL | 2026-Q2: $10,000 in income | 1 |
| ONE CALL, CORP | 2026-Q2: $15,000 in income | 1 |
| OPUS GENETICS, INC | 2026-Q2: $15,000 in income | 1 |
| ORCHARD THERAPEUTICS NORTH AMERICA | 2026-Q2: $10,000 in income | 1 |
| ORGANON & CO. | 2026-Q2: $5,000 in income | 1 |
| PAR HEALTH USA, LLC | 2026-Q2: $15,000 in income | 1 |
| PHARMING HEALTHCARE, INC. | 2026-Q2: $10,000 in income | 1 |
| PHATHOM PHARMACEUTICALS | 2026-Q2: $15,000 in income | 1 |
Lobbyists named in these reports
- BRETT MEEKS · 62 reports · earlier government job reported
- DAVID RUDLOFF · 63 reports
- JEFFREY J KIMBELL · 63 reports
- JOHN HERZOG · 62 reports · earlier government job reported
- JOHN R RAY · 62 reports · earlier government job reported
- KEITH STUDDARD · 62 reports · earlier government job reported
- KENNETH LEE HODGE · 63 reports
- KRISTIN FRITSCH · 61 reports · earlier government job reported
- LAURA KEMPER · 63 reports · earlier government job reported
Bills named, and how the House and the Senate voted
6 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 2199Restore Protections for Dialysis Patients Act | Introduced | No recorded vote in our record |
| H.R. 2527Early Detection of Vision Impairments for Children Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 6214Kidney Care Access Protection Act | Introduced | No recorded vote in our record |
| H.R. 7389Motor Vehicle Modernization Act of 2026 | Introduced | No recorded vote in our record |
| S. 1173Restore Protections for Dialysis Patients Act | Introduced | No recorded vote in our record |
| S. 2730Kidney Care Access Protection Act | Introduced | No recorded vote in our record |
Issues named: Health Issues (50), Medicare/Medicaid (26), Trade (domestic/foreign) (4), Agriculture (2), Defense (2), Animals (1), Budget/Appropriations (1), Consumer Issues/Safety/Products (1), Housing (1), Labor Issues/Antitrust/Workplace (1), Pharmacy (1).
Every report
| Client, sort A to Z | Kind, as filed, sort A to Z | Posted, sort oldest first | Report |
|---|---|---|---|
| CATALYST PHARMACEUTICALSHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| HARMONY BIOSCIENCES, LLCHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ARDELYX, INC.Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GENUS LIFESCIENCESHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.)Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| U.S. RENAL CAREMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ACCURAY INCORPORATEDTrade (domestic/foreign), Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GLAUKOS CORPORATION (FKA AVEDRO, INC.)Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| TERUMO BCTMedicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| SSI GROUPHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| LIVANOVA USA INCMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GALVANIZE THERAPEUTICS, INC. | 2nd Quarter - Termination (No Activity) | The report on LDA.gov | |
| THE ALLERGY, ASTHMA & SINUS CENTERHealth Issues, Medicare/Medicaid | 2nd Quarter - Termination | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.